BlackRock Capital Allocation Term Trust to Issue Monthly Dividend of $0.25 (NYSE:BCAT)

Key Points

• BCAT declared a monthly dividend of $0.2542 per share, payable August 31 to shareholders of record on August 14. The dividend represents an approximately 19.0% annualized yield.
• Shares opened at $16.09, near the 12-month high of $16.20, with 50-day and 200-day moving averages of $15.77 and $15.25, respectively.
• Institutional investors own 36.12% of BCAT, while several investment firms recently increased their positions, including Geneos Wealth Management, Brown Brothers Harriman and McIlrath & Eck.

BlackRock Capital Allocation Term Trust (NYSE:BCAT - Get Free Report) declared a monthly dividend on Friday, June 5th. Stockholders of record on Friday, August 14th will be given a dividend of 0.2542 per share on Monday, August 31st. This represents a c) annualized dividend and a dividend yield of 19.0%. The ex-dividend date is Friday, August 14th.

BlackRock Capital Allocation Term Trust Price Performance

Shares of BCAT stock opened at $16.09 on Wednesday. BlackRock Capital Allocation Term Trust has a 12-month low of $13.73 and a 12-month high of $16.20. The firm has a fifty day moving average of $15.77 and a 200-day moving average of $15.25.

Hedge Funds Weigh In On BlackRock Capital Allocation Term Trust

Large investors have recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. lifted its holdings in shares of BlackRock Capital Allocation Term Trust by 341.7% in the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company's stock valued at $31,000 after purchasing an additional 1,582 shares in the last quarter. N.E.W. Advisory Services LLC grew its holdings in shares of BlackRock Capital Allocation Term Trust by 100.0% during the fourth quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company's stock worth $34,000 after buying an additional 1,200 shares in the last quarter. McIlrath & Eck LLC raised its position in BlackRock Capital Allocation Term Trust by 169.6% in the 1st quarter. McIlrath & Eck LLC now owns 3,130 shares of the company's stock valued at $44,000 after buying an additional 1,969 shares during the last quarter. Parallel Advisors LLC acquired a new stake in BlackRock Capital Allocation Term Trust in the 3rd quarter valued at approximately $47,000. Finally, Brown Brothers Harriman & Co. lifted its stake in BlackRock Capital Allocation Term Trust by 450.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 5,500 shares of the company's stock valued at $81,000 after acquiring an additional 4,500 shares in the last quarter. Institutional investors own 36.12% of the company's stock.

BlackRock Capital Allocation Term Trust Company Profile

BlackRock Capital Allocation Term Trust NYSE: BCAT is a closed-end, diversified management investment company organized as a term trust. The fund's primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source